A breakthrough pill, baxdrostat, has shown remarkable success in lowering dangerously high blood pressure in patients resistant to standard treatments. In a large international trial, it cut systolic pressure by nearly 10 mmHg, enough to significantly reduce risks of heart attack, stroke, and kidney disease. The drug works by blocking excess aldosterone, a hormone that drives uncontrolled hypertension.
A breakthrough pill, baxdrostat, has shown remarkable success in lowering dangerously high blood pressure in patients resistant to standard treatments. In a large international trial, it cut systolic pressure by nearly 10 mmHg, enough to significantly reduce risks of heart attack, stroke, and kidney disease. The drug works by blocking excess aldosterone, a hormone that drives uncontrolled hypertension. A breakthrough pill, baxdrostat, has shown remarkable success in lowering dangerously high blood pressure in patients resistant to standard treatments. In a large international trial, it cut systolic pressure by nearly 10 mmHg, enough to significantly reduce risks of heart attack, stroke, and kidney disease. The drug works by blocking excess aldosterone, a hormone that drives uncontrolled hypertension.